OTCMKTS:HPPI HedgePath Pharmaceuticals (HPPI) Stock Price, News & Analysis → CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (From Banyan Hill Publishing) (Ad) Free HPPI Stock Alerts $0.09 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$0.09▼$0.0950-Day Range$0.06▼$0.1452-Week Range$0.04▼$0.32VolumeN/AAverage Volume19,283 shsMarket Capitalization$32.97 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Get HedgePath Pharmaceuticals alerts: Email Address Ad Huge AlertsWhy Is Gold On a MASSIVE rally? Gold has been on a tear this year. The yellow metal has hit an all-time high of $2,4231.29 recently and the rally could be far from over. From central banks to even Costco customers, it seems everyone is buying gold these days. With Wall Street watching the gold space carefully, now is a perfect time to pay attention to this stock.This Little known Company is a uniquely structured for profit About HedgePath PharmaceuticalsHedgePath Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for patients with cancers and non-cancerous proliferation disorders in the United States. It primarily focuses on the development of therapies for skin, lung, and prostate cancers. The company's Hedgehog signaling pathway is a primary regulator of cellular processes in vertebrates, including stem cell maintenance, cell differentiation, tissue polarity, and cell proliferation. It also develops super bioavailability (SUBA)-itraconazole oral capsules for patients with basal cell carcinoma nevus syndrome. SUBA-Itraconazole is a patented itraconazole formulation that enhances the absorption of itraconazole to enhance the bioavailability of orally administered drugs that are poorly soluble. The company was founded in 1992 and is headquartered in Tampa, Florida. HedgePath Pharmaceuticals, Inc. is a subsidiary of Mayne Pharma Ventures Pty Ltd.Read More HPPI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HPPI Stock News HeadlinesFebruary 17, 2024 | wsj.comEagle Pharmaceuticals Inc.See More Headlines Receive HPPI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HedgePath Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Commercial Physical Research Sub-IndustryN/A Current SymbolOTCMKTS:HPPI CUSIPN/A CIK1042418 Webwww.hedgepathpharma.com Phone813-509-2417FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,550,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-246.03% Debt Debt-to-Equity RatioN/A Current Ratio6.76 Quick Ratio6.76 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.01) per share Price / Book-8.90Miscellaneous Outstanding Shares370,446,000Free FloatN/AMarket Cap$32.97 million OptionableNot Optionable Beta-1.16 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Nicholas Jon Virca (Age 73)Pres & CEO Mr. Garrison J. Hasara CPA (Age 50)CPA, CFO, Treasurer, Sec. & Chief Compliance Officer Key CompetitorsStarpharmaOTCMKTS:SPHRYbioAffinity TechnologiesNASDAQ:BIAFAIkido PharmaNASDAQ:AIKIInotivNASDAQ:NOTVBioqualOTCMKTS:BIOQView All Competitors HPPI Stock Analysis - Frequently Asked Questions How have HPPI shares performed in 2024? HedgePath Pharmaceuticals' stock was trading at $0.0920 at the start of the year. Since then, HPPI stock has decreased by 3.3% and is now trading at $0.0890. View the best growth stocks for 2024 here. What other stocks do shareholders of HedgePath Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other HedgePath Pharmaceuticals investors own include TransAtlantic Petroleum (TAT), Eaton (ETN), Diamond Offshore Drilling (DO), Correvio Pharma (CORV), Clorox (CLX), CIT Group (CIT), Bank of Montreal (BMO), Blue Sphere (BLSP), BJ's Wholesale Club (BJ) and Alimentation Couche-Tard (ATD.B). How do I buy shares of HedgePath Pharmaceuticals? Shares of HPPI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:HPPI) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA ‘DeFi Summer’ Projected!Crypto 101 MediaUrgent Nvidia WarningAltimetryBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HedgePath Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.